Changes Democrats Seek To Part B Demo Could Neuter It, Lobbyists Say

The changes that House and Senate Democrats are urging CMS to make to the proposed Part B drug demonstration could gather steam because lawmakers reportedly discussed them with the White House, which now faces criticism from its own party over the agency's plan to lower Part B drug costs. Unlike Republicans, Democrats aren’t asking CMS to terminate the demo, yet the changes they are requesting would pull many of its teeth, a drug lobbyist says. Senate Democrats, including the party’s...